ESG Data

As of July 15, 2026

We have posted data related to our ESG.

Environment

 

Item

Unit

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

 FY2025

Scope

Greenhouse gas emissions Scope 1

t-CO₂

 1,989

1,934

 2,070

2,016

 1,945 2,036 1,971 2,081 Eiken Group 1

Greenhouse gas emissions Scope 2

t-CO₂

5,181

4,884

5,038

 5,302 2,669 706 678 207

Greenhouse gas emissions Scope 1 and 2

t-CO₂

7,170

6,818

7,108

7,318

 4,614 2,742 2,649 2,288
Greenhouse gas emissions Scope 3 2  　Total t-CO2 ー ー 86,485 105,335 84,205 71,697 77,708 101,027

　Cat.1 Purchased goods and services

 t-CO2 ー ー 50,206 55,450 47,826 47,842 51,315 52,150
　Cat.2 Capital goods t-CO2 ー ー 5,383 3,385 18,707 5,060 6,540 28,890
　Cat.3 Fuel- and energy-related activities not included in scope 1 or scope 2 t-CO2 ー ー 995 1,045 1,121 1,191 1,168 1,352
　Cat.4 Upstream transportation and distribution t-CO2 ー ー 1,670 2,181 1,914 1,565 1,702 1,574
　Cat.5 Waste generated in operations t-CO2 ー ー 53 59 75 73 64 58
　Cat.6 Business travel t-CO2 ー ー 133 138 137 137 137 138
　Cat.7 Employee commuting t-CO2 ー ー 696 625 631 618 629 609
　Cat.8 Upstream leased assets t-CO2 ー ー Not relevant Not relevant Not relevant Not relevant Not relevant Not relevant
　Cat.9 Downstream transportation and distribution t-CO2 ー ー 21,145 36,098 8,306 9,839 10,899 11,197
　Cat.10 Processing of sold products t-CO2 ー ー Not relevant Not relevant Not relevant Not relevant Not relevant Not relevant
　Cat.11 Use of sold products t-CO2 ー ー 2,549 1,895 2,172 2,124 1,805 1,808
　Cat.12 End-of-life treatment of sold products t-CO2 ー ー 3,654 4,458 3,316 3,248 3,449 3,251
　Cat.13 Downstream leased assets t-CO2 ー ー Not relevant Not relevant Not relevant Not relevant Not relevant Not relevant
　Cat.14 Franchises t-CO2 ー ー Not relevant Not relevant Not relevant Not relevant Not relevant Not relevant
　Cat.15 Investments t-CO2 ー ー Not relevant Not relevant Not relevant Not relevant Not relevant Not relevant

Electricity

 in-house power generation
(Renewable-energy)
(solar energy)

Mwh

76

70

61

62

 98 109 126 94 Eiken Group
Purchased electricity
(Renewable-energy)
(non-fossil)		 Mwh ー ー ー ー 6,774 11,655 11,423 14,001
Purchased electricity
(Non-renewable-energy)		 Mwh 10,356 10,042 10,492 11,040 5,260 1,106 1,057 405
Total electricity consumption Mwh 10,433 10,112 10,553 11,102 12,131 12,870 12,605 14,499
Amount of renewable energy used Mwh 76 70 61 62 6,871 11,764 11,548 14,095
Renewable energy utilization rate % 0.7 0.7 0.6 0.6 56.6 91.4 91.8 97.2

Water volume consumed 　

1000cu.m

83.9

81.0

78.1

80.7

 73.1 68.7 69.1 62.0 Eiken Group （Production sites）

Wastewater volume

1000cu.m

71.8

74.3

69.4

67.5

 63.0 53.9 51.0 45.3  

Energy consumption rate (crude-oil equivalent)3

kl

2,954

2,921

2,988

3,326

 3,440 3,274 3,212 3,781 Eiken Chemical Co., Ltd.

Total waste emissions 4

t

384

438

429

464

 517 398 415 488 Eiken Group （Head Office/Production sites/Laboratories）

Waste used for material recycling

t

215

233

223

233

 247 238 227 241  

Recycled waste (including energy recovery)

t

215

264

255

273

 283 246 266 317  

Recycling rate (including energy recovery)

％

56.0

60.2

59.4

58.8

 54.7 61.8 64.2 65.0  

Total amount of waste disposal 5

t

169

175

170

191

 236 152 149 171  

Number of eco-proposals

Proposals

445

454

318

291

 518 525 567 523 Eiken Chemical Co., Ltd.

*GHG Scope1: Direct emission from own fuel usage or usage in manufacturing processes of the Company
*GHG Scope2: Indirect emissions from usage of electricity or heat purchased by the Company
*GHG Scope3: Indirect emissions related to processes other than Scope1 and Scope2 (procurement of raw materials, product shipment, usage, and disposal, employee commuting, business trips, etc.)　

1 Eiken Group：Eiken Chemical Co., Ltd. , Eiken China Co., Ltd. (Transfer of equity interest in FY2025).
2 Calculated according to Scope 3 items based on the GHG Protocol for items covered by Eiken Group.  The calculation method will be changed from value-based to weight-based starting in FY2022.
3 Regular reports based on the Energy Conservation Act.　Values from  FY2023  are based on the revised Energy Conservation Act.
4 Waste emissions = general waste emissions + industrial waste emissions + recycled waste (including energy recovery)
5 Total amount of waste disposal =total emissions - recycled waste (including energy recovery)

Third-Party Verification

To improve the reliability of our environmental performance data, we have obtained an independent third-party verification provided by ond Inc.

Third-Party Verification Statement

Social

Item

Unit

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

 FY2025

No.consolidated employees

All employees

People

1,040

1,053

1,087

 1,105 1,106 1,101 1,051 1,060

Full-time employees

People

719

724

733

 745 754 757 702 695
Temp employees People 321 329 354 360 352 344 349 364

No. non-consolidated employees 

All employees

People

983

992

1025

 1,044 1,052 1,053 1,047 1,060

Full-time employees

People

673

677

684

 697 708 713 700 695
Temp employees People 310 315 341 347 344 340 347 364

No. subsidiary employees(EIKEN CHINA CO., LTD.)

Transfer of equity interest in FY2025

 All employees People 58 60 60 59 49 49 5 0
Full-time employees People 45 47 48 47 45 45 2 0
Temp employees People 13 13 12 12 4 4 3 0
No. female employees Full-time employees People 195 199 203 211 207 213 212 217

Female employees as share of total

Full-time employees

%

29.0

29.4

29.7

 30.3 29.2 29.9 30.3 31.2

No. employees in management 1

People

148

144

136

 130 123 130 133 134

No. female manager 1

People

18

21

23

 21 17 20 25 25
  • Percentage of female managers 1

%

12.2

14.6

16.9

 16.2 13.8 15.4 18.8 18.7

No. new hires

People

45

35

40

 41 40 44 41 46

No. new graduates hires

People

26

19

20

 26 19 23 23 19

New graduates as share of total new hires

%

57.8

54.3

50.0

 63.4 47.5 52.3 56.1 41.3

No. new mid-career hires

People

19

16

20

 15 21 21 18 27

Mid-career hires as share of total new hires

%

42.2

45.7

50.0

 36.6 52.5 47.7 43.9 58.7

No. female new hires

People

16

7

11

 12 7 16 16 14
  • Proportion of women among new hires

%

35.6

20.0

27.5

 29.3 17.5 36.4 39.0 30.4
  • Employment rate of persons with disabilities

%

1.8

2.3

2.6

 2.4 2.6 2.7 2.7 3.2

Number of Full time staff voluntary turnover

Male

People

5

12

5

 10 12 9 10 10

Female

People

1

2

7

 4 7 8 4 6

Full time staff voluntary turnover rates 2

%

0.9

2.0

1.7

 2.0 2.7 2.3 1.9 2.3

Avg. no. years continuous service

Male

Years

16yrs.
2mo.

14yrs.
11mo.

16yrs.
2mo.

 15yrs.
7mo.		 15yrs.
7mo.		 14yrs.10mo. 14yrs.2mo. 13yrs.
1mo.

Female

Years

16yrs.
1mo.

16yrs.
6mo.

16yrs.
9mo.

 16yrs.
10mo.		 17yrs.
7mo.		 16yrs.10mo. 15yrs.11mo. 15yrs.
5mo.
Differences in Wages between Male and Female employees 3 All employees % ー ー ー ー 65.4 68.9 68.4 68.1
Full-time employees % ー ー ー ー 88.3 91.7 90.4 87.5
Temp employees % ー ー ー ー 47.1 49.4 51.1 53.3

Avg. no. days of paid leave taken per full-time employee

Days

6.7

10.4

10.6

 11.4 11.5 12.6 11.9 13.0

Rate of uptake of paid leave per full-time employee

%

37.8

50.3

58.0

 62.1 62.1 67.3 63.7 70.7

Total actual work hours per full-time employee per year 4

Hours

2,072

1,917

1,929

 1,894 1,875 1,864 1,841 1,835

Avg. no. hrs. of overtime work per month
(per full-time employee)

Hours

14.1

15.8

16.2

 15.3 14.8 13.9 12.8 13.1

Rate of uptake of childcare leave
(Including leave taken for childbirth of spouse)

Male 5

%

88.9

94.5

81.8

 73.1 176.9 90.0 91.7 100

Female 6

%

100

83.3

100

 66.7 100 100 114.3 100
Return-to-work rate after parental leave % 100 100 100 100 100 100 100 100

Stress checks

 Participation rate

%

97.1

98.5

98.7

 98.8 99.2 98.8 99.0 99.1
Overall health risks ー 100 104 97 96 95 97 97 94
Rate of high stress people % 13.8 16.8 12.4 12.2 11.9 13.4 14.3 14.9

Rate of uptake of regular health checkups

%

100

100

100

 99.9 99.8 100 100 100

Rate of uptake of secondary (detailed) clinical tests 7

%

55

58

52

 46 61 56 63.4

Data Pending
Smoking rates % ー ー ー ー ー ー 16.5 14.7
Rate of employees subject to specific health guidance % ー ー ー ー ー ー 17.8 16.8
Participation rates in specific healthcare guidance 8 % ー ー ー ー 91.2 75.2 48.7 25.2
Lifestyle disease finding rate Hypertension % ー ー ー ー ー ー 21.4 Data Pending
Diabetes % ー ー ー ー ー ー 17.1 Data Pending
Dyslipidemia % ー ー ー ー ー ー 38.5 Data Pending
Employee healthy weight rate % ー ー ー ー ー ー 66.2 66.1
Rate of uptake e-learning courses on health % ー ー ー ー 77.3 100 100 100

Rate of uptake of harassment prevention training

%

ー

ー

84.8

 100 100 100 100 100

Number of occupational accidents (incl. traffic accidents)　

Accidents

8

7

8

 2 3 10 13 11

Number of days absent per employee

(Absenteeism 9)

 ー ー ー ー ー 2.97 1.21 1.51 2.68

Overall evaluation of work performance

(Presenteeism)

 ー ー ー ー ー 94.0 93.9 93.7 93.9

Rate of uptake of EGP training among young employees 10

%

ー

ー

16.5

 14.0 19.4 26.3 27.2 20.6
  • Total training hours
 hours ー ー ー ー ー ー 6,189 7,876
Employee satisfaction score 11 ー ー ー ー ー

68.6

(Previous Calculation Method)

62.1

(Previous Calculation Method)

58.8

(Previous Calculation Method)

 80.6

Open Innovation Indicator (Number of Employees on External Secondment)

People

ー

ー

ー

 ー ー ー 4 Data Pending

Consolidated: Eiken Chemical Co., Ltd. and Eiken China Co., Ltd.
Non-consolidated: Eiken Chemical Co., Ltd. (all data other than “Consolidated no. employees” is non-consolidated (Eiken Chemical only))

1 In management: Managerial positions of section-manager level or higher
2 Calculated using: Numerator: No. full-time employees leaving the Company within the fiscal year (April 1 to March 31) , Denominator: No. full-time employees as of April 1 of the fiscal year
3 Calculated based on the provisions of the Act on Promotion of Women's Participation and Advancement in the Workplace (Act No. 64 of 2015)
The gender pay gap shows the ratio of women's wages to men's wages.
[All employees] There is no difference in wages for the same work, and the wage gap between men and women is due to differences in the composition of personnel by grade.
[Part/fixed-term employees] A high percentage of men are rehired after retirement with specialties, resulting in a gender wage gap.
4 No. scheduled work hours + no. non-scheduled work hours – annual paid leave and other paid leave
5 Denominator: Number of male employees whose spouse gave birth during the fiscal year;Numerator: Number of male employees who used our company's original leave program for parental leave and childcare during the fiscal year　
(Depending on when the spouse gave birth, employees who take childcare leave in the following fiscal year are included, so the acquisition rate may exceed 100%.)
6 Denominator: Number of female employees who gave birth during the fiscal year; Numerator: Number of female employees who took childcare leave during the fiscal year
(Depending on the time of childbirth, employees who will take childcare leave in the following fiscal year are included, so the acquisition rate may exceed 100%.)
7 Share of employees eligible for detailed clinical tests who undergo such tests at a facility designated by the  Health Insurance Society
8 Since specific health guidance may be conducted over multiple sessions, the completion period may extend into the following fiscal year, which can result in fluctuations in the reported participation rate.
9 Calculated using: Numerator: Total number of days of leave (calendar days) for all employees in each fiscal year, Denominator: Number of employees at the end of each fiscal year
10 Rate of uptake of the Eiken Global Program: No. Program participants in each fiscal year ÷ no. employees of the fiscal year
11 Calculated from the percentage of people who gave positive responses on a five-point scale in the employee satisfaction survey.

 

Governance

Item

Unit

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

No. directors

People

9

9

9

9

 8 8 8 10

No. outside directors

People

6

6

6

6

 5 5 5 7

Outside directors as share of directors　

%

67

67

67

67

 63 63 63 70

No. female directors

People

1

1

1

1

 1 1 1 2

Female directors as share of directors　

%

11

11

11

11

 13 13 13 20

Board of Directors attendance rate

%

98

98

100

100

 100 100 100 100
(As of June)

Composition of Nomination Committee

Inside directors

People

1

1

1

1

 1 1 1 0

Outside directors

People

2

2

2

2

 2 2 2 3

Of whom: Female

People

0

0

0

0

 0 0 0 0

Composition of Remuneration Committee

Inside directors

People

1

1

1

1

 1 1 1 0

Outside directors

People

2

2

2

2

 2 2 2 3

Of whom: Female

People

0

0

0

0

 0 0 0 1

Composition of Audit Committee

Inside directors

People

0

0

0

1

 1 0 1 0

Outside directors

People

3

3

3

2

 2 3 3 4

Of whom: Female

People

1

1

1

1

 1 1 1 2

No. executive officers

People

11

9

10

10

 10 10 10 11

No. female executive officers

People

0

0

0

0

 0 0 0 0

Female executive officers as share of total

%

0

0

0

0

 0 0 0 0

Training Participation Rate and Survey Monitoring

%

ー

ー

ー

100

 100 100 100 100

Significant Violations of Competition and Anti-Corruption Laws

 Incidents ー ー ０ 0 0 0 0 0

BCP Training and Review of BCP Documentation

 % ー ー 100 100 100 100 100 100

Material Information Leakage Incidents 1

Incidents

ー

ー

0

0

 0 0 0 0

1　Total Number of Significant Violations of Competition Laws, Anti-Corruption Regulations, and Other Socioeconomic Laws and Regulations

Sustainability

 
Medical
Environment
Social
Governance